RBMXL3

Model summary

A nuclear RNA-binding regulator that assembles on pre-mRNA through an RRM-centered platform to control alternative splicing and mRNA fate. By engaging pre-mRNA and recruiting spliceosomal factors in the nucleoplasm and nucleolus, it modulates exon choice and thereby shapes differentiation programs, including those of keratinocytes. Its mechanism relies on high-affinity RNA recognition coupled to multivalent protein interactions that stabilize spliceosome-associated ribonucleoprotein assemblies.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminus houses IPR012677 (Nucleotide-binding alpha-beta plait domain superfamily, residues 2–137), a structural scaffold that frequently supports nucleic acid–binding folds. Nested within this region is IPR035979 (RNA-binding domain superfamily, residues 9–115), and centrally embedded is IPR000504 (RNA recognition motif domain, residues 8–86). This canonical RRM core is followed and extended by IPR050441 (RNA-binding motif family, residues 3–306), which spans nearly the full length and indicates an extended RNA-binding platform beyond the classical RRM. The ordered layout—an N-terminal alpha-beta plait supporting an RRM core that is further extended by additional RNA-binding family features—creates a high-affinity, sequence-selective RNA-binding module. This architecture causes direct mRNA engagement and multivalent protein contacts typical of splicing regulators.

2. 02

   From this domain logic, the molecular function resolves into two complementary activities.

   First, the RRM-centered module confers GO:0003729 mRNA binding by directly recognizing single-stranded regions of pre-mRNA and mRNA. Second, the extended RNA-binding family signature and exposed beta-sheet surfaces promote assembly with other ribonucleoprotein factors, supporting GO:0005515 protein binding. Together, these features equip the protein to dock onto pre-mRNA while recruiting or stabilizing spliceosomal components.

3. 03

   These molecular activities drive specific biological processes.

   By binding pre-mRNA and organizing spliceosomal assemblies, the protein regulates splice-site choice, aligning with GO:0000381 regulation of alternative mRNA splicing, via spliceosome. Its splicing control cascades into tissue-specific programs; modulation of keratin and signaling transcripts provides a mechanistic route into GO:0030216 keratinocyte differentiation, where alternative splicing patterns steer epidermal lineage decisions.

4. 04

   Cellular localization follows from function and architecture.

   Splicing regulation occurs in the nuclear interior, particularly in the GO:0005654 nucleoplasm where spliceosome assembly and catalysis take place. The presence of nucleic acid–binding folds and splicing roles also rationalizes transient residence in the GO:0005730 nucleolus, a hub for RNP biogenesis and RNA-processing factor storage/assembly. The soluble, non-membranous architecture and absence of transmembrane features reinforce a nuclear, nucleoplasmic working site with nucleolar shuttling.

5. 05

   Mechanistically, the RRM core binds pre-mRNA near regulated exons/introns, while the extended RNA-binding platform stabilizes spliceosomal components to bias exon inclusion/skipping.

   I hypothesize that it forms ribonucleoprotein assemblies with SR proteins and hnRNPs to fine-tune exon choice. Likely partners include U2AF heterodimer components and SF3 complexes that define the branchpoint and E/A complexes, as well as keratinocyte-enriched RNA-binding factors that couple splicing to differentiation cues. This cooperative assembly provides the specificity and regulatory leverage required for alternative splicing and downstream epidermal differentiation programs.